How Peptides Are Made: Solid-Phase Synthesis, Explained Plainly

Nearly all research peptides are made by solid-phase peptide synthesis, the method Merrifield introduced in the early 1960s and which has been refined continuously since, most notably into the Fmoc chemistry that dominates today.[1] The defining idea is that the growing chain stays anchored to an insoluble resin bead, so excess reagents and by-products can be washed away at every step instead of requiring a purification after each one.

The chain is built backwards relative to how sequences are written, starting from the C-terminus:

• ·The first amino acid is coupled to the resin.
• ·Each subsequent residue is added in a cycle: deprotect the growing chain's reactive end, couple the next protected amino acid, wash.
• ·After the final residue, the chain is cleaved from the resin and the side-chain protecting groups are removed.
• ·The crude product is purified, typically by preparative HPLC, then lyophilised into the powder that ships in a vial.

Amino Acid Sequence

Every coupling cycle succeeds at slightly under 100%. That is not a failure of care, it is the chemistry: a bimolecular reaction on a solid support goes to high conversion, not to complete conversion. Chains that miss a cycle become deletion sequences, the target peptide minus one residue, and they carry on through the remaining cycles as a shadow population.

The consequence is arithmetic. A 15-residue peptide runs about 14 coupling cycles. A 44-residue peptide runs about 43. Even at very high per-cycle efficiency, the fraction of chains that made every single coupling falls as the sequence lengthens, which is why long peptides are harder to make pure, why crude synthesis has to be purified rather than shipped, and why the HPLC purity figure exists at all: it measures how completely the deletion sequences and by-products were removed.[2]

Amino Acid Sequence

• ·Purity varies between lots, honestly. Coupling efficiency, purification cuts and lyophilisation recovery all vary run to run. Real certificates show 99.2% on one lot and 99.8% on the next. Uniform perfection across an entire catalogue is a documentation pattern rather than a manufacturing one.
• ·Modifications cost real money. Lipidation, an albumin-binding group, N-terminal stabilisation, C-terminal amidation: each adds synthesis steps, reagent cost and yield loss. A price far below market for a heavily modified compound is telling you a step was skipped somewhere.
• ·Length predicts price better than mechanism does. A three-residue sequence is cheap chemistry regardless of how interesting its biology is. Cost tracks cycles and modifications, which is why the price spread across a catalogue is not arbitrary. The full breakdown is in peptide pricing in Canada.
• ·The certificate is the product. Every vial's quality is set by one lot's synthesis and purification run, so a lot-level test is the only quality statement with any content. A product-level claim describes an intention.

Cleavage from the resin and removal of the protecting groups produces a crude mixture: the target sequence, the deletion sequences, and reaction by-products. Preparative HPLC separates them, and here a real trade-off appears. Cutting the collection window tightly gives higher purity and lower yield; cutting it generously gives more product and more impurity. That decision is a cost decision, and it is one place a low price can come from.

Lyophilisation then freeze-dries the purified solution into the stable powder that ships. The powder form is what makes ambient-temperature shipping workable, and it is why handling constraints mostly begin after reconstitution rather than in transit.

Available at Eppix Labs

Buy Tesamorelin Canada | 10mg & 20mg

10mg · 20mg

Every batch tested by an independent laboratory, with the certificate published before sale.

From $75.00 CADIn stock